Lori Isom, PhD, FANA
University of Michigan Medical School
Dr. Lori Isom is the Maurice H. Seevers Professor and Chair of the Department of Pharmacology at the University of Michigan Medical School. Her laboratory investigates voltage-gated sodium channels and the roles of sodium channel gene variants in developmental and epileptic encephalopathy using a combination of mouse models, human iPSC neurons and cardiac myocytes, and transgenic rabbits. She collaborated with Stoke Therapeutics to develop the first gene-modifying therapy for Dravet syndrome. Dr. Isom is Co-PI of the NINDS EpiMVP Center Without Walls, co-chair of the Dravet Syndrome Foundation Scientific Advisory Board, and previous board member of the American Epilepsy Society. She is a Fellow of the AAAS, Fellow of the American Society for Pharmacology and Experimental Therapeutics, and Fellow of the American Epilepsy Society, and was elected to the National Academy of Medicine.